BenzaClin

This page contains recent news articles, when available, and an overview of BenzaClin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Sanofi-Aventis to buy Gold Bond maker Chattem  -  ‎Dec 21, 2009‎
Viehbacher cited allergy spray Nasacort, acne treatment BenzaClin and Penlac for fungal nail infections. Over-the-counter drugs provide steady revenue that ... The Associated Press

Sanofi-Aventis adj net profit up 16%, ups guidance  -  ‎Oct 30, 2009‎
Excluding amortization charges against intangible assets, impairment losses on drugs Benzaclin, Nasacort and Actonel, and deferred taxes, it would have ... MarketWatch

Valeant Pharmaceuticals International Q3 2009 Earnings Call Transcript  -  ‎Nov 2, 2009‎
Our royalties generated from Dow including generic BenzaClin are $22 million for the first nine months of 2009, well ahead of our original forecast. ... Seeking Alpha (blog)

Study compares effects of clin-BPO 2.5% and clin-BPO 5% on epidermal functions  -  ‎Oct 21, 2009‎
...and twice-daily clin-BPO 5% (BenzaClin ® Topical Gel) according to the dosage and administration sections of each product's respective package insert ... News-Medical.net

Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009  -  ‎Oct 30, 2009‎
Impairment losses of euro 352 million, of which euro 344 million was booked in the third quarter, mainly in respect of Benzaclin®, Nasacort® and Actonel® in ... Reuters





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy